Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nada Bogdanovic-Sakran

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Viruses|September 28, 2024
Rotavirus-Specific Maternal Serum Antibodies and Vaccine Responses to RV3-BB Rotavirus Vaccine Administered in a Neonatal or Infant Schedule in MalawiBenjamin Morgan, Eleanor A Lyons, Amanda Handley, et al.
The New England Journal of Medicine|February 22, 2018
Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from BirthJulie E Bines, Jarir At Thobari, Cahya Dewi Satria, et al.
Nature Communications|April 10, 2025
Early-life gut microbiome associates with positive vaccine take and shedding in neonatal schedule of the human neonatal rotavirus vaccine RV3-BBJosef Wagner, Amanda Handley, Celeste M Donato, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Viruses|September 28, 2024
Rotavirus-Specific Maternal Serum Antibodies and Vaccine Responses to RV3-BB Rotavirus Vaccine Administered in a Neonatal or Infant Schedule in MalawiBenjamin Morgan, Eleanor A Lyons, Amanda Handley, et al.
The New England Journal of Medicine|February 22, 2018
Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from BirthJulie E Bines, Jarir At Thobari, Cahya Dewi Satria, et al.
Nature Communications|April 10, 2025
Early-life gut microbiome associates with positive vaccine take and shedding in neonatal schedule of the human neonatal rotavirus vaccine RV3-BBJosef Wagner, Amanda Handley, Celeste M Donato, et al.
Pageof 4